Actively Recruiting

Phase Not Applicable
Age: 21Years +
FEMALE
ID07195656

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) EVANESCE-II

Led by FemPulse Corporation · Updated on 2026-02-06

151

Participants Needed

15

Research Sites

30 weeks

Total Duration

On this page

Sponsors

F

FemPulse Corporation

Lead Sponsor

M

Moxie Clinical

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the safety and effectiveness of the FemPulse System, a non-implanted electrical stimulation device, for women with overactive bladder (OAB). This condition includes symptoms like urinary urgency, frequent urination, and nighttime urination, with or without urgency urinary incontinence. The study is sponsored by FemPulse Corporation and compares this device to medication treatments for OAB. Participants will be randomly assigned to one of two groups. One group will use the FemPulse System, which delivers vaginal electrical stimulation without implantation. The other group will receive standard OAB medication. The study will assess the changes in the number of times participants urinate each day over a 6-month period. Women who join the study will need to follow study procedures such as consistent medication use, managing fluid intake, and completing diaries about their symptoms. Researchers will monitor their urinary patterns and safety throughout the study. The main outcome measured is the average change in daily voiding frequency after six months of treatment.

CONDITIONS

Brief Title

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Who Can Participate

Age: 21Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female with a uterus and cervix
  • At least 21 years old
  • Diagnosed with overactive bladder with symptoms lasting more than 6 months
  • Willing and able to comply with study procedures including consistent medication use, fluid intake, and diary completion
Not Eligible

You will not qualify if you...

  • Having a systemic condition or disease that may interfere with study participation, such as current systemic infection, uncontrolled autoimmune disease, uncontrolled immunodeficiency disease, or history of myocardial infarction
  • Determined not an appropriate study candidate by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 6 months

Participants receive either a non-implanted vaginal electrical stimulation device or medication to treat overactive bladder symptoms.

Monthly visits during treatment

Trial Site Locations

Total: 15 locations

1

Cedars Sinai

Beverly Hills, California, United States, 90211

Actively Recruiting

2

UCLA

Los Angeles, California, United States, 90095

Not Yet Recruiting

3

UC Irvine

Orange, California, United States, 92868

Actively Recruiting

4

Stanford

Palo Alto, California, United States, 94304

Actively Recruiting

5

USCD

San Diego, California, United States, 92037

Not Yet Recruiting

6

Holy Cross Medical Group - Women's Center

Fort Lauderdale, Florida, United States, 33334

Not Yet Recruiting

7

Comprehensive Urologic

Barrington, Illinois, United States, 60010

Actively Recruiting

8

University of Louisville

Louisville, Kentucky, United States, 40205

Not Yet Recruiting

9

Chesapeake Urology

Owings Mills, Maryland, United States, 21117

Actively Recruiting

10

Minnesota Urology

Woodbury, Minnesota, United States, 55125

Not Yet Recruiting

11

Adult & Pediatric Urology

Omaha, Nebraska, United States, 68114

Actively Recruiting

12

Atrium Health

Charlotte, North Carolina, United States, 28204

Not Yet Recruiting

13

Southern Urogynecology

West Columbia, South Carolina, United States, 29169

Actively Recruiting

14

Sanford Health

Sioux Falls, South Dakota, United States, 57105

Actively Recruiting

15

INOVA

Falls Church, Virginia, United States, 22042

Not Yet Recruiting

Loading map...

Research Team

M

Monica Unger

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

The APPROVE Trial: Evaluating a Prescription Digital Therape...

Overactive Bladder (OAB)

Actively Recruiting

10 locations

Prospective, Multicenter, Single Arm Feasibility and Safety ...

Urinary Urge Incontinence (UUI)

Actively Recruiting

1 location

Characterizing the Postmenopausal Genitourinary Microbiome i...

Overactive Bladder (OAB)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here